The Discounted Cash Flow (DCF) valuation of Voyager Therapeutics Inc (VYGR) is (17.20) USD. With the latest stock price at 2.94 USD, the upside of Voyager Therapeutics Inc based on DCF is -685.1%.
Based on the latest price of 2.94 USD and our DCF valuation, Voyager Therapeutics Inc (VYGR) is a sell. selling VYGR stocks now will result in a potential gain of 685.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 7.2% | 6.0% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (156.46) - (8.81) | (17.20) |
| Upside | -5421.8% - -399.6% | -685.1% |